Use of parvovirus capsid particles in the inhibition of cell proliferation and migration
CA 2352043 A1 · Owner: Tripep Ab · Inventors: Westgren, Magnus; Broliden, Kristina
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention described herein relates to the discovery of methods and compositions for the inhibition of growth and/or migration of cells that have the P antigen, including but not limited to cells of hematopoietic origin and , endothelial cells. More specifically parvovirus capsid particles or fragments of parvovirus capsid proteins are used to manufacture medicaments that can be administered to a subject to inhibit hematopoietic progenitor cell growth (e.g. prior to stem cell transplantation) endothelial cell growth, (e.g. as , an anti-tumorigenesis treatment or to prevent restenosis or fibrotic build up following prosthetic implantation), or to prevent disorders that involve the …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 23, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 23, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 23, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.